Passage Bio, Inc. (PASG) Tops Q2 EPS by 3c

Passage Bio, Inc. (NASDAQ: PASG) reported Q2 EPS of ($0.44), $0.03 better than the analyst estimate of ($0.47).

For earnings history and earnings-related data on Passage Bio, Inc. (PASG) click here.

You May Also Be Interested In

• AngioDynamics (ANGO) Tops Q4 EPS by 2c ; Offers Guidance
• Cruise industry faces yield pressure amid geopolitical concerns
• Beam Global reports Q2 2026 revenue above $8.5M, up 170% from Q1